INDIAN BIOSERVICES INDUSTRY HITS RS 29,000 CR WITH 12% GROWTH IN 2019-20 Indian BioServices industry comprising over 1000 players in the field of clinical research, contract research, contract development and manufacturing has seen significant growth in the recent past and witnessed a 12 per cent growth in 2019-20 by reaching Rs 29,120 crore as against 19 per cent growth recorded in 2018-19. Contract research, development and manufacturing are contributing the most in BioServices industry with less than 10 per cent coming from clinical research organisations. For Feedback, please email us at : communications@mmactiv.com --
The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc